Missense mutations in the beta-myosin heavy chain (beta-MHC) gene cause hypertrophic cardiomyopathy (HCM). As normal and mutant beta-MHCs are expressed in slow-twitch skeletal muscle of HCM patients, we compared the contractile properties of single slow-twitch muscle fibers from patients with three distinct beta-MHC gene mutations and normal controls. Fibers with the 741Gly-->Arg mutation (near the binding site of essential light chain) demonstrated decreased maximum velocity of shortening (39% of normal) and decreased isometric force generation (42% of normal). Fibers with the 403Arg-->Gln mutation (at the actin interface of myosin) showed lowered force/stiffness ratio (56% of normal) and depressed velocity of shortening (50% of normal). Both the 741Gly-->Arg and 403Arg-->Gln mutation-containing fibers displayed abnormal force-velocity relationships and reduced power output. Fibers with the 256Gly-->Glu mutation (end of ATP-binding pocket) had contractile properties that were indistinguishable from normal. Thus there is variability in the nature and extent of functional impairments in skeletal fibers containing different beta-MHC gene mutations, which may correlate with the severity and penetrance of the disease that results from each mutation. These functional alterations likely constitute the primary stimulus for the cardiac hypertrophy that is characteristic of this disease.
E B Lankford, N D Epstein, L Fananapazir, H L Sweeney
Title and authors | Publication | Year |
---|---|---|
Chronic moderate‑intensity exercise can induce physiological hypertrophy in aged cardiomyocytes through autophagy, with minimal Yap/Taz involvement
Limyati Y, Lucretia T, Gunadi JW, Vitriana V, Jasaputra DK, De Mello Wahyudi K, Lesmana R |
Biomedical Reports | 2025 |
Mechano-energetic efficiency in patients with hypertrophic cardiomyopathy with and without sarcomeric mutations.
Borrelli F, Lombardi R, Canciello G, Frisso G, Todde G, Esposito G, Losi MA |
Journal of Cardiovascular Translational Research | 2023 |
Assessing Cardiac Contractility From Single Molecules to Whole Hearts
Garg A, Lavine KJ, Greenberg MJ |
JACC: Basic to Translational Science | 2023 |
Critical Evaluation of Current Hypotheses for the Pathogenesis of Hypertrophic Cardiomyopathy.
Ušaj M, Moretto L, Månsson A |
International journal of molecular sciences | 2022 |
Cardiac ventricular myosin and slow skeletal myosin exhibit dissimilar chemomechanical properties despite bearing the same myosin heavy chain isoform
Wang T, Spahiu E, Osten J, Behrens F, Grünhagen F, Scholz T, Kraft T, Nayak A, Amrute-Nayak M |
The Journal of biological chemistry | 2022 |
Complexity in genetic cardiomyopathies and new approaches for mechanism-based precision medicine
MJ Greenberg, JC Tardiff |
The Journal of General Physiology | 2021 |
Alpha and beta myosin isoforms and human atrial and ventricular contraction
J Walklate, C Ferrantini, CA Johnson, C Tesi, C Poggesi, MA Geeves |
Cellular and Molecular Life Sciences | 2021 |
Novel mutations in β-MYH7 gene in Indian patients with dilated cardiomyopathy
DS Rani, AV Kumar, P Nallari, K Sampathkumar, PS Dhandapany, C Narasimhan, A Rathinavel, K Thangaraj |
2021 | |
Novel Mutations in β-MYH7 Gene in Indian Patients With Dilated Cardiomyopathy.
Rani DS, Vijaya Kumar A, Nallari P, Sampathkumar K, Dhandapany PS, Narasimhan C, Rathinavel A, Thangaraj K |
2021 | |
Sarcopenia: Aging-Related Loss of Muscle Mass and Function
L Larsson, H Degens, M Li, L Salviati, Y il Lee, W Thompson, JL Kirkland, M Sandri |
Physiological reviews | 2019 |
Phenotypic variation and targeted therapy of hypertrophic cardiomyopathy using genetic animal models
MP Gannon, MS Link |
Trends in Cardiovascular Medicine | 2019 |
The R249Q hypertrophic cardiomyopathy myosin mutation decreases contractility in Drosophila by impeding force production
KM Bell, WA Kronert, A Huang, SI Bernstein, DM Swank |
The Journal of Physiology | 2019 |
CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy
D Mosqueira, I Mannhardt, JR Bhagwan, K Lis-Slimak, P Katili, E Scott, M Hassan, M Prondzynski, SC Harmer, A Tinker, JG Smith, L Carrier, PM Williams, D Gaffney, T Eschenhagen, A Hansen, C Denning |
European Heart Journal | 2018 |
Transcriptome analysis reveals potential mechanisms underlying differential heart development in fast- and slow-growing broilers under heat stress
J Zhang, CJ Schmidt, SJ Lamont |
BMC Genomics | 2017 |
Biophysical properties of human β-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy
M Kawana, SS Sarkar, S Sutton, KM Ruppel, JA Spudich |
Science Advances | 2017 |
Throttling back the heart's molecular motor
DM Warshaw |
Science | 2016 |
Cryo-EM structure of a human cytoplasmic actomyosin complex at near-atomic resolution
J der Ecken, SM Heissler, S Pathan-Chhatbar, DJ Manstein, S Raunser |
Nature | 2016 |
A Combined Linkage and Exome Sequencing Analysis for Electrocardiogram Parameters in the Erasmus Rucphen Family Study
CT Silva, IV Zorkoltseva, N Amin, A Demirkan, EM van Leeuwen, JA Kors, M Berg, BH Stricker, AG Uitterlinden, AV Kirichenko, JC Witteman, R Willemsen, BA Oostra, TI Axenovich, CM van Duijn, A Isaacs |
Frontiers in Genetics | 2016 |
Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human β-Cardiac Myosin
AS Adhikari, KB Kooiker, SS Sarkar, C Liu, D Bernstein, JA Spudich, KM Ruppel |
Cell Reports | 2016 |
Early onset hypertrophic cardiomyopathy mutations significantly increase the velocity, force, and actin-activated ATPase activity of human β-cardiac myosin
Adhikari AS, Kooiker KB, Sarkar SS, Liu C, Bernstein D, Spudich JA, Ruppel KM |
Cell Reports | 2016 |
A traditional Chinese medicine, Lujiao prescription, as a potential therapy for hypertrophic cardiomyocytes by acting on histone acetylation
W Zhao, W Hu, X Wang, N Xia, Q Hu, H Zhou |
Journal of the Chinese Medical Association | 2015 |
Titin mutations: the fall of Goliath
M Neiva-Sousa, J Almeida-Coelho, I Falcão-Pires, AF Leite-Moreira |
Heart Failure Reviews | 2015 |
Contractility parameters of human -cardiac myosin with the hypertrophic cardiomyopathy mutation R403Q show loss of motor function
S Nag, RF Sommese, Z Ujfalusi, A Combs, S Langer, S Sutton, LA Leinwand, MA Geeves, KM Ruppel, JA Spudich |
Science Advances | 2015 |
Pathophysiology and Pharmacotherapy of Cardiovascular Disease
G Jagadeesh, P Balakumar, K Maung-U |
2015 | |
Muscle dysfunction in hypertrophic cardiomyopathy: What is needed to move to translation?
C Poggesi, CY Ho |
Journal of Muscle Research and Cell Motility | 2014 |
Familial hypertrophic cardiomyopathy: functional variance among individual cardiomyocytes as a trigger of FHC-phenotype development
B Brenner, B Seebohm, S Tripathi, J Montag, T Kraft |
Frontiers in physiology | 2014 |
Comprehensive Physiology
SN Cheuvront, RW Kenefick |
Comprehensive Physiology | 2014 |
Hypertrophic cardiomyopathy: how do mutations lead to disease?
JD Marsiglia, AC Pereira |
Arquivos brasileiros de cardiologia | 2014 |
Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation: Increased tension cost in human HCM with the MYH7 R403Q mutation
ER Witjas-Paalberends, C Ferrara, B Scellini, N Piroddi, J Montag, C Tesi, GJ Stienen, M Michels, CY Ho, T Kraft, C Poggesi, J der Velden |
The Journal of Physiology | 2014 |
Cell-Intrinsic Functional Effects of the α-Cardiac Myosin Arg-403-Gln Mutation in Familial Hypertrophic Cardiomyopathy
P Chuan, S Sivaramakrishnan, EA Ashley, JA Spudich |
Biophysical Journal | 2012 |
Hypertrophic cardiomyopathy: Translating cellular cross talk into therapeutics
P Teekakirikul, RF Padera, JG Seidman, CE Seidman |
The Journal of Cell Biology | 2012 |
Understanding Cardiomyopathy Phenotypes Based on the Functional Impact of Mutations in the Myosin Motor
JR Moore, L Leinwand, DM Warshaw, J Robbins, C Seidman, H Watkins |
Circulation research | 2012 |
Functional characterization of the human α-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy
M Müller, AJ Mazur, E Behrmann, RP Diensthuber, MB Radke, Z Qu, C Littwitz, S Raunser, CA Schoenenberger, DJ Manstein, HG Mannherz |
Cellular and Molecular Life Sciences | 2012 |
Structural Basis for Myopathic Defects Engendered by Alterations in the Myosin Rod
A Cammarato, XE Li, MC Reedy, CF Lee, W Lehman, SI Bernstein |
Journal of Molecular Biology | 2011 |
Mechanical and Energetic Consequences of HCM-Causing Mutations
C Ferrantini, A Belus, N Piroddi, B Scellini, C Tesi, C Poggesi |
Journal of Cardiovascular Translational Research | 2009 |
The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils: Human cardiac myofibril mechanics and R403Q myosin
A Belus, N Piroddi, B Scellini, C Tesi, GD Amati, F Girolami, M Yacoub, F Cecchi, I Olivotto, C Poggesi |
The Journal of Physiology | 2008 |
Protein Science Encyclopedia
G Schmitz, T Langmann |
Protein Science Encyclopedia | 2008 |
Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone
S Lowey, LM Lesko, AS Rovner, AR Hodges, SL White, RB Low, M Rincon, J Gulick, J Robbins |
The Journal of biological chemistry | 2008 |
Functional Effects of the Hypertrophic Cardiomyopathy R403Q Mutation Are Different in an α- or β-Myosin Heavy Chain Backbone
S Lowey, LM Lesko, AS Rovner, AR Hodges, SL White, RB Low, M Rincon, J Gulick, J Robbins |
The Journal of biological chemistry | 2008 |
Regulatory Mechanisms of Striated Muscle Contraction
S Ebashi, I Ohtsuki |
2007 | |
Regulatory Mechanisms of Striated Muscle Contraction
S Ebashi, I Ohtsuki |
2007 | |
Regulatory Mechanisms of Striated Muscle Contraction
S Ebashi, I Ohtsuki |
2007 | |
Regulatory Mechanisms of Striated Muscle Contraction
S Ebashi, I Ohtsuki |
2007 | |
Regulatory Mechanisms of Striated Muscle Contraction
S Ebashi, I Ohtsuki |
2007 | |
Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse α-cardiac myosin in the laser trap assay
EP Debold, JP Schmitt, JB Patlak, SE Beck, JR Moore, JG Seidman, C Seidman, DM Warshaw |
American journal of physiology. Heart and circulatory physiology | 2007 |
Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients
D Szczesna-Cordary, M Jones, JR Moore, J Watt, WG Kerrick, Y Xu, Y Wang, C Wagg, GD Lopaschuk |
The FASEB Journal | 2007 |
Cardiovascular Medicine
JT Willerson, HJ Wellens, JN Cohn, DR Holmes |
2007 | |
Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease
P Charron, M Komajda |
Expert Review of Molecular Diagnostics | 2006 |
The Genetic Bases of Cardiomyopathies
P Richard, E Villard, P Charron, R Isnard |
Journal of the American College of Cardiology | 2006 |
Functional Studies of Individual Myosin Molecules
JA Dantzig, TY Liu, YE Goldman |
Annals of the New York Academy of Sciences | 2006 |
Clinical Characteristics of Heart Disease Patients With a Good Prognosis in Spite of Markedly Increased Plasma Levels of Type-B Natriuretic Peptide (BNP)
I Takeuchi, T Inomata, M Nishii, T Koitabashi, H Nakano, H Shinagawa, H Takehana, T Izumi |
Circulation Journal | 2005 |
Hypertrophic cardiomyopathy-related beta-myosin mutations cause highly variable calcium sensitivity with functional imbalances among individual muscle cells
SE Kirschner, E Becker, M Antognozzi, HP Kubis, A Francino, F Navarro-López, N Bit-Avragim, A Perrot, MM Mirrakhimov, KJ Osterziel, WJ McKenna, B Brenner, T Kraft |
American journal of physiology. Heart and circulatory physiology | 2004 |
Cardiovascular Pharmacogenetics
MR Wilkins |
2004 | |
Heterologous expression of wild-type and mutant beta-cardiac myosin changes the contractile kinetics of cultured mouse myotubes
G Miller, J Maycock, E White, M Peckham, S Calaghan |
The Journal of Physiology | 2003 |
Hypertrophic cardiomyopathy: from gene defect to clinical disease
MW CHUNG, T TSOUTSMAN, C SEMSARIAN |
Cell Research | 2003 |
Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion
H Ashrafian, C Redwood, E Blair, H Watkins |
Trends in Genetics | 2003 |
Genetic Basis for Hypertrophic Cardiomyopathy: Implications for Diagnosis and Treatment
R Roberts, J Sidhu |
The American Heart Hospital Journal | 2003 |
Utility of Genetic Screening in Hypertrophic Cardiomyopathy: Prevalence and Significance of Novel and Double (Homozygous and Heterozygous)β-Myosin Mutations
SA Mohiddin, DA Begley, E McLam, JP Cardoso, JB Winkler, JR Sellers, L Fananapazir |
Genetic Testing | 2003 |
Suppression of muscle hypercontraction by mutations in the myosin heavy chain gene of Drosophila melanogaster
U Nongthomba, M Cummins, S Clark, JO Vigoreaux, JC Sparrow |
Genetics | 2003 |
Handbook of Clinical Neurophysiology
L Larsson |
Handbook of Clinical Neurophysiology | 2003 |
Subclinical skeletal muscle abnormalities in patients with hypertrophic cardiomyopathy and their relation to clinical characteristics
A Anastasakis, N Karandreas, P Stathis, A Rigopoulos, A Theopistou, R Sepp, PM Elliott, DB Panagiotakos, C Stefanadis, P Toutouzas |
International Journal of Cardiology | 2003 |
Clinical and epidemiological aspects of cardiomyopathies: a critical review of current knowledge
M Sangiorgi |
European Journal of Internal Medicine | 2003 |
Mutations in the motor domain modulate myosin activity and myofibril organization
Q Wang, CL Moncman, DA Winkelmann |
Journal of cell science | 2003 |
Suppression of Muscle Hypercontraction by Mutations in the Myosin Heavy Chain Gene of Drosophila melanogaster
U Nongthomba, M Cummins, S Clark, JO Vigoreaux, JC Sparrow |
Genetics | 2003 |
New molecular insights into heart failure and cardiomyopathy: potential strategies and therapies
GA MacGowan, DM McNamara |
Irish Journal of Medical Science | 2002 |
A Gradient of Myosin Regulatory Light-chain Phosphorylation across the Ventricular Wall Supports Cardiac Torsion
J Davis, S Hassanzadeh, S Winitsky, H Wen, A Aletras, N Epstein |
Cold Spring Harbor Symposia on Quantitative Biology | 2002 |
Genética molecular de las miocardiopatías
R Roberts |
Revista Española de Cardiología | 2002 |
α1-Syntrophin–deficient skeletal muscle exhibits hypertrophy and aberrant formation of neuromuscular junctions during regeneration
Y Hosaka, T Yokota, Y Miyagoe-Suzuki, K Yuasa, M Imamura, R Matsuda, T Ikemoto, S Kameya, S Takeda |
The Journal of Cell Biology | 2002 |
Molecular Mechanisms of Inherited Cardiomyopathies
D Fatkin, RM Graham |
Physiological reviews | 2002 |
Molecular Interactions of Actin
DD Thomas, CG Remedios |
2002 | |
Mechanism of Regulation of Acanthamoeba Myosin-IC by Heavy-Chain Phosphorylation
EM Ostap, T Lin, SS Rosenfeld, N Tang |
Biochemistry | 2002 |
The Overall Pattern of Cardiac Contraction Depends on a Spatial Gradient of Myosin Regulatory Light Chain Phosphorylation
JS Davis, S Hassanzadeh, S Winitsky, H Lin, C Satorius, R Vemuri, AH Aletras, H Wen, ND Epstein |
Cell | 2001 |
The molecular genetic basis for hypertrophic cardiomyopathy
AJ Marian, R Roberts |
Journal of Molecular and Cellular Cardiology | 2001 |
Molecular genetics and pathogenesis of hypertrophic cardiomyopathy
AJ Marian, L Salek, S Lutucuta |
Minerva medica | 2001 |
Heart Physiology and Pathophysiology
NS Dhalla, RM Temsah, T Netticadan, MS Sandhu |
Heart Physiology and Pathophysiology | 2001 |
Formation of the Heart and Its Regulation
RJ Tomanek, RB Runyan |
2001 | |
Comparison of Two Murine Models of Familial Hypertrophic Cardiomyopathy
BK McConnell, D Fatkin, C Semsarian, KA Jones, D Georgakopoulos, CT Maguire, MJ Healey, JO Mudd, IP Moskowitz, DA Conner, M Giewat, H Wakimoto, CI Berul, FJ Schoen, DA Kass, CE Seidman, JG Seidman |
Circulation research | 2001 |
R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level
K A Palmiter, M J Tyska, J R Haeberle, N R Alpert, L Fananapazir, D M Warshaw |
Journal of Muscle Research and Cell Motility | 2001 |
FROM THESARCOMERE TO THENUCLEUS: Role of Genetics and Signaling in Structural Heart Disease
RL Nicol, N Frey, EN Olson |
Annual Review of Genomics and Human Genetics | 2000 |
Electromyographic evidence of subclinical myopathy in hypertrophic cardiomyopathy
N Karandreas, P Stathis, A Anastasakis, A Rigopoulos, P Piperos, A Theopistou, C Stefanadis, P Toutouzas |
Muscle & Nerve | 2000 |
Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes
S Sharma, PM Elliott, G Whyte, N Mahon, MS Virdee, B Mist, WJ McKenna |
Journal of the American College of Cardiology | 2000 |
Animal models of hypertrophic cardiomyopathy
A Maass, LA Leinwand |
Current Opinion in Cardiology | 2000 |
Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy
ST Li, CJ Tack, L Fananapazir, DS Goldstein |
Journal of the American College of Cardiology | 2000 |
A Novel Missense Mutation, Leu390Val, in the Cardiac ß-myosin Heavy Chain Associated with Pronounced Septal Hypertrophy in Two Families with Hypertrophic Cardiomyopathy
OH Pa |
Scandinavian Cardiovascular Journal | 2000 |
Remodeling the Cardiac Sarcomere Using Transgenesis
J Robbins |
Annual Review of Physiology | 2000 |
Inherited and de novo Mutations in the Cardiac Actin Gene Cause Hypertrophic Cardiomyopathy
TM Olson, TP Doan, NY Kishimoto, FG Whitby, MJ Ackerman, L Fananapazir |
Journal of Molecular and Cellular Cardiology | 2000 |
Single-Molecule Mechanics of R403Q Cardiac Myosin Isolated From the Mouse Model of Familial Hypertrophic Cardiomyopathy
MJ Tyska, E Hayes, M Giewat, CE Seidman, JG Seidman, DM Warshaw |
Circulation research | 2000 |
Enhanced Myosin Function Due to a Point Mutation Causing a Familial Hypertrophic Cardiomyopathy
RL Moss, JS Periera |
Circulation research | 2000 |
Advances in Noninvasive Electrocardiographic Monitoring Techniques
HH Osterhues, V Hombach, AJ Moss |
2000 | |
Aging-Related Changes in Skeletal Muscle: Mechanisms and Interventions
L Larsson, B Ramamurthy |
Drugs & Aging | 2000 |
The Hypertrophied Heart
N Takeda, M Nagano, NS Dhalla |
2000 | |
Molecular Approaches to Heart Failure Therapy
G Hasenfuss, E Marbán |
2000 | |
Molecular genetics of card iomyopathies*1
G Shah |
Journal of Nuclear Cardiology | 2000 |
Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the α cardiac myosin heavy chain gene
D Fatkin, ME Christe, O Aristizabal, BK McConnell, S Srinivasan, FJ Schoen, CE Seidman, DH Turnbull, JG Seidman |
Journal of Clinical Investigation | 1999 |
STRUCTURAL MECHANISM OF MUSCLE CONTRACTION>
MA Geeves, KC Holmes |
Annual Review of Biochemistry | 1999 |
A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy
A Varnava, C Baboonian, F Davison, L Cruz, PM Elliott, MJ Davies, WJ McKenna |
Heart (British Cardiac Society) | 1999 |
Structural Analysis of the Titin Gene in Hypertrophic Cardiomyopathy: Identification of a Novel Disease Gene
M Satoh, M Takahashi, T Sakamoto, M Hiroe, F Marumo, A Kimura |
Biochemical and Biophysical Research Communications | 1999 |
Early events of cardiovascular development
TA Drysdale |
Seminars in Neonatology | 1999 |
Functional changes in troponin T by a splice donor site mutation that causes hypertrophic cardiomyopathy
H Nakaura, S Morimoto, F Yanaga, M Nakata, H Nishi, T Imaizumi, I Ohtsuki |
American journal of physiology. Cell physiology | 1999 |
An α-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes
SJ Kim, K Iizuka, RA Kelly, YJ Geng, SP Bishop, G Yang, A Kudej, BK McConnell, CE Seidman, JG Seidman, SF Vatner |
American journal of physiology. Heart and circulatory physiology | 1999 |
Altered Crossbridge Kinetics in the αMHC 403/+ Mouse Model of Familial Hypertrophic Cardiomyopathy
E Blanchard, C Seidman, JG Seidman, M LeWinter, D Maughan |
Circulation research | 1999 |
Contemporary Concepts in Cardiology
R Gorlin, G Dangas, PK Toutouzas, MM Konstadoulakis |
1999 | |
Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy
M Spindler, KW Saupe, ME Christe, HL Sweeney, CE Seidman, JG Seidman, JS Ingwall |
Journal of Clinical Investigation | 1998 |
Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice
L Oberst, G Zhao, JT Park, R Brugada, LH Michael, ML Entman, R Roberts, AJ Marian |
Journal of Clinical Investigation | 1998 |
Molecular Genetic Basis of Hypertrophic Cardiomyopathy:
AJ Marian, R Roberts |
Journal of Cardiovascular Electrophysiology | 1998 |
Impaired Peripheral Vasoconstriction in Response to Alpha-Adrenergic Stimulation in Patients With Idiopathic Hypertrophic Cardiomyopathy
S Kawano, K Iida, I Nishi, Y Iwasaki, T Masumi, Y Sugishita, I Yamaguchi |
Japanese Circulation Journal | 1998 |
The role of cytoskeletal proteins in cardiomyopathies
JA Towbin |
Current Opinion in Cell Biology | 1998 |
Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy
O Roopnarine, LA Leinwand |
Biophysical Journal | 1998 |
Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function
HL Sweeney, HS Feng, Z Yang, H Watkins |
Proceedings of the National Academy of Sciences | 1998 |
Cardiopulmonary responses to exercise in patients with hypertrophic cardiomyopathy
S Jones, PM Elliott, S Sharma, WJ McKenna, BJ Whipp |
Heart (British Cardiac Society) | 1998 |
Hypertrophic Cardiomyopathy — Beyond the Sarcomere
MS Sutton, JA Epstein |
New England Journal of Medicine | 1998 |
Functional Analysis of Myosin Mutations That Cause Familial Hypertrophic Cardiomyopathy
O Roopnarine, LA Leinwand |
Biophysical Journal | 1998 |
Hypertrophic Cardiomyopathy: Role of the Implantable Cardioverter-Defibrillator
JP MD, PG MD, JB MD, AL MD, LM MD, FW MD, MV MD, PB MD |
Journal of the American College of Cardiology | 1998 |
Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms
MC Schaub, MA Hefti, RA Zuellig, I Morano |
Cardiovascular Research | 1998 |
Familial Hypertrophic Cardiomyopathy: From Mutations to Functional Defects
G Bonne, L Carrier, P Richard, B Hainque, K Schwartz |
Circulation research | 1998 |
A Mutant Tropomyosin That Causes Hypertrophic Cardiomyopathy Is Expressed In Vivo and Associated With an Increased Calcium Sensitivity
R Bottinelli, DA Coviello, CS Redwood, MA Pellegrino, BJ Maron, P Spirito, H Watkins, C Reggiani |
Circulation research | 1998 |
Cardiac Myosin Binding Protein C Gene Is Specifically Expressed in Heart During Murine and Human Development
F Fougerousse, AL Delezoide, MY Fiszman, K Schwartz, JS Beckmann, L Carrier |
Circulation research | 1998 |
Mechanisms of Work Production and Work Absorption in Muscle
H Sugi, GH Pollack |
1998 | |
[Genetic causes of hypertrophic cardiomyopathy].
Vosberg HP |
1998 | |
Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication
H Fujita, S Sugiura, S Momomura, M Omata, H Sugi, K Sutoh |
Journal of Clinical Investigation | 1997 |
Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates
JC Bowman, SF Steinberg, T Jiang, DL Geenen, GI Fishman, PM Buttrick |
Journal of Clinical Investigation | 1997 |
Subaortic septal bulge simulates hypertrophic cardiomyopathy by angulation of the septum with age, independent of focal hypertrophy. An echocardiographic study
N Krasnow |
Journal of the American Society of Echocardiography | 1997 |
Hypertrophic Cardiomyopathy: valuation and Treatment of Patients at High Risk for Sudden Death
L Fananapazir, DO McAREAVEY |
Pacing and Clinical Electrophysiology | 1997 |
In vitro motility assay of atrial and ventricular myosin from pig
C Svensson, I Morano, A Arner |
Journal of Cellular Biochemistry | 1997 |
Abnormal skeletal muscle bioenergetics in familial hypertrophic cardiomyopathy
CH Thompson, GJ Kemp, DJ Taylor, M Conway, B Rajagopalan, A O'Donoghue, P Styles, WJ McKenna, GK Radda |
Heart (British Cardiac Society) | 1997 |
The Myocardium
H Zhu |
The Myocardium | 1997 |
Point Mutations in Human β Cardiac Myosin Heavy Chain Have Differential Effects on Sarcomeric Structure and Assembly: An ATP Binding Site Change Disrupts Both Thick and Thin Filaments, Whereas Hypertrophic Cardiomyopathy Mutations Display Normal Assembly
KD Becker, KR Gottshall, R Hickey, JC Perriard, KR Chien |
The Journal of Cell Biology | 1997 |
Expression of a Mutant (Arg 92 Gln) Human Cardiac Troponin T, Known to Cause Hypertrophic Cardiomyopathy, Impairs Adult Cardiac Myocyte Contractility
AJ Marian, G Zhao, Y Seta, R Roberts, Q Yu |
Circulation research | 1997 |
Inhibition of Myocardial Crossbridge Cycling by Hypoxic Endothelial Cells: A Potential Mechanism for Matching Oxygen Supply and Demand?
AM Shah, A Mebazaa, ZK Yang, G Cuda, EB Lankford, CB Pepper, SJ Sollott, JR Sellers, JL Robotham, EG Lakatta |
Circulation research | 1997 |
Organization and Sequence of Human Cardiac Myosin Binding Protein C Gene (MYBPC3) and Identification of Mutations Predicted to Produce Truncated Proteins in Familial Hypertrophic Cardiomyopathy
L Carrier, G Bonne, E Bahrend, B Yu, P Richard, F Niel, B Hainque, C Cruaud, F Gary, S Labeit, JB Bouhour, O Dubourg, M Desnos, AA Hagege, RJ Trent, M Komajda, M Fiszman, K Schwartz |
Circulation research | 1997 |
The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy
G Cuda, L Fananapazir, N D Epstein, J R Sellers |
Journal of Muscle Research and Cell Motility | 1997 |
Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy
D Lin, A Bobkova, E Homsher, LS Tobacman |
Journal of Clinical Investigation | 1996 |
Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart
WK Jones, IL Grupp, T Doetschman, G Grupp, H Osinska, TE Hewett, G Boivin, J Gulick, WA Ng, J Robbins |
Journal of Clinical Investigation | 1996 |
Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action
H Watkins, CE Seidman, JG Seidman, HS Feng, HL Sweeney |
Journal of Clinical Investigation | 1996 |
Contractile protein mutations and heart disease
KL Vikstrom, LA Leinwand |
Current Opinion in Cell Biology | 1996 |
Regional left ventricular contractile dynamics in hypertrophic cardiomyopathy evaluated by magnetic resonance imaging
T Sato, H Yamanari, T Ohe, T Yoshinouchi |
Heart and Vessels | 1996 |
Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle
K Poetter, H Jiang, S Hassanzadeh, SR Master, A Chang, MC Dalakas, I Rayment, JR Sellers, L Fananapazir, ND Epstein |
Nature Genetics | 1996 |
THE MAMMALIAN MYOSIN HEAVY CHAIN GENE FAMILY
A Weiss, LA Leinwand |
Annual Review of Cell and Developmental Biology | 1996 |
Myosin diversity and disease
AF Wright, I Jackson |
Trends in Genetics | 1996 |
Molecular diversity of myofibrillar proteins: gene regulation and functional significance
R Bottinelli, C Reggiani |
Physiological reviews | 1996 |
Recent advances in the molecular genetics of hypertrophic cardiomyopathy
AJ Marian, R Roberts |
Circulation | 1995 |
Prevalence of Hypertrophic Cardiomyopathy and Limitations of Screening Methods
L Fananapazir, ND Epstein |
Circulation | 1995 |
Advances in Genetics
BH Bowman, F Yang, GS Adrian |
Advances in genetics | 1988 |